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Notch signalingThe Hedgehog (Hh) signaling network is critical for patterning and organogenesis in mammals, and has been
implicated in a variety of cancers. Smoothened (Smo), the gene encoding the principal signal transducer, is
overexpressed frequently in breast cancer, and constitutive activation in MMTV-SmoM2 transgenic mice
caused alterations in mammary gland morphology, increased proliferation, and changes in stem/progenitor
cell number. Both in transgenic mice and in clinical specimens, proliferative cells did not usually express
detectable Smo, suggesting the hypothesis that Smo functioned in a non-cell autonomous manner to
stimulate proliferation. Here, we employed a genetically tagged mouse model carrying a Cre-recombinase-
dependent conditional allele of constitutively active Smo (SmoM2) to test this hypothesis. MMTV-Cre- or
adenoviral-Cre-mediated SmoM2 expression in the luminal epithelium, but not in the myoepithelium, was
required for the hyper-proliferative phenotypes. High levels of proliferation were observed in cells adjacent or
in close-proximity to Smo expressing cells demonstrating that SmoM2 expressing cells were stimulating
proliferation via a paracrine or juxtacrine mechanism. In contrast, Smo expression altered luminal cell
differentiation in a cell-autonomous manner. SmoM2 expressing cells, puriﬁed by ﬂuorescence activated cell
sorting (FACS) via the genetic ﬂuorescent tag, expressed high levels of Ptch2, Gli1, Gli2, Jag2 and Dll-1, and
lower levels of Notch4 and Hes6, in comparison to wildtype cells. These studies provide insight into the
mechanism of Smo activation in the mammary gland and its possible roles in breast tumorigenesis. In
addition, these results also have potential implications for the interpretation of proliferative phenotypes
commonly observed in other organs as a consequence of hedgehog signaling activation.east Center, Baylor College of
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The Hedgehog (Hh) signaling network plays essential roles in
patterning and organogenesis during metazoan development. In
mammals, Hh signaling regulates morphogenesis, cell fate, and
stem/progenitor cell maintenance, and functions in virtually every
organ and structure in the body, including the mammary gland (Jia
and Jiang, 2006; McMahon et al., 2003). Mutations in several Hh
network genes, or deregulated network activity, have been implicated
in the development of a variety of cancers including those of the skin,
lung, pancreas, gastrointestinal system, prostate, and breast
(reviewed in (Chari and McDonnell, 2007; Evangelista et al., 2006;
Kasper et al., 2009; Varjosalo and Taipale, 2008; Visbal and Lewis,
2010).Mammary gland development is a highly regulated process
governed by both systemic hormones and local growth factors- and
adhesion-mediated epithelial–stromal and epithelial–epithelial cell
interactions. Development in virgin animals is largely limited to
ductal elongation and branching morphogenesis, as well as differen-
tiation of the luminal and myoepithelial cell types present in the
mature virgin ducts (Watson and Khaled, 2008). While limited
alveolar development does occur in virgin mammals in some species
(e.g. humans), functional differentiation of the mammary gland does
not occur until pregnancy and lactation with the development of
secretory alveolar structures and milk production.
Our work and the work of others have demonstrated key roles for
selected Hh network genes in mediating epithelial–stromal interac-
tions in virgin mice. While no mammary functions have been ascribed
to any of the three Hh ligands, Patched-1 (Ptch1), which acts as an
inhibitor of network signaling in the absence of a hedgehog ligand,
and as a signal transducing receptor in their presence, is required in
both the epithelium and the mammary stroma (as well as system-
ically) for normal ductal morphogenesis (Moraes et al., 2009). Gli2, a
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is also required in the mammary stroma for proper duct patterning
(Lewis et al., 2001). In addition to these loss-of-function studies,
overexpression analyses in transgenic mice have shown defects in
mammary gland morphology and altered stem/progenitor cell
number in mice expressing constitutively activated Smoothened
(Smo), the Hh pathway's main signal transducer (Moraes et al., 2007).
Additionally, lactation defects and tumor formation in multiparous
mice were observed in transgenic animals expressing the Gli1
transcription factor (Fiaschi et al., 2009; Fiaschi et al., 2007).
In previous studies from our laboratory, we demonstrated that
Smo is frequently ectopically expressed in human breast cancers,
particularly in ductal carcinoma in situ (DCIS), an early breast cancer
lesion. About seventy percent of DCIS lesions, and about thirty percent
of invasive breast cancers (IBC), showed ectopic expression relative to
normal mammary epithelium in which expression was not detectable
(Moraes et al., 2007). Consistent with a potential role in breast cancer,
expression of a constitutively activated form of Smo (SmoM2) under
the control of the mouse mammary tumor virus (MMTV) promoter
indicated that Smo activation in a small percentage (~5%) of luminal
mammary epithelial cells led to increased proliferation and abnormal
ductal morphology of the mammary gland (Moraes et al., 2007). Both
in transgenic mice and in clinical specimens, proliferative cells did not
usually express detectable Smo, suggesting the possibility that Smo
functioned in a non-cell autonomous paracrine or juxtacrine manner
to stimulate proliferation. In both Ptch1 loss-of-function and MMTV-
SmoM2 mice (both mutations generally leading to ectopic signaling),
there was no evidence that canonical Gli-mediated Hh signaling was
active, as evidenced by lack of increased expression of autoregulated
network genes (e.g. Ptch1, Gli1, Gli2). Thus, both the cellular and
molecular mechanisms underlying the effects of abnormal Smo
expression in the mouse or human mammary gland remained
unclear.
In this study, we took advantage of a conditional knock-in mouse
model that allows expression of a SmoM2–YFP fusion protein upon
Cre-mediated recombination under the control of the endogenous
Rosa26 promoter to increase the percentage of cells expressing
SmoM2. Additionally, we employed a dual ﬂuorescent Cre-responsive
reporter line that allowed us to genetically tag SmoM2 expressing
cells and distinguish them from wild type cells. The use of these
models allowed us to differentiate whether the effects of Smo
activation were cell-autonomous, or whether they were being
mediated by a paracrine/juxtacrine mechanism. Additionally, ﬂuor-
escently tagged cells could be puriﬁed using ﬂuorescence activated
cell sorting (FACS) to examine the activation state of the hedgehog
network in Smo expressing cells relative to the surrounding wildtype
cells.
Materials and methods
Mouse strains and breeding
The previously described R26SmoM2, herein referred to as
SmoM2, and the dual ﬂuorescence mT-mG Cre-recombinase reporter
mouse lines (Fig. S1) were obtained from Jackson Laboratories (stock
numbers 005130 and 007576, respectively) and maintained in a
mixed genetic background (Jeong et al., 2004; Muzumdar et al.,
2007). The MMTV-Cre (Li et al., 2002) and R26R Cre-dependent LacZ
reporter (Soriano, 1999) lines were generous gifts from T. Lane
(UCLA, Los Angeles, CA) and P. Soriano (Fred Hutchinson Cancer
Research Center, Seattle, WA), respectively. For our initial studies in
which the epithelium was not genetically tagged with a Cre reporter,
F1 SmoM2/+; MMTV-Cre and SmoM2/+ littermates were used. For
some subsequent transplantation experiments, SmoM2/SmoM2 mice
were crossed to R26R/R26R animals to create a genetically tagged
line expressing LacZ in cells undergoing Cre-mediated recombina-tion. For experiments in which the epithelium was tagged with a
ﬂuorescent reporter, the SmoM2 line was backcrossed four genera-
tions into FVB and then intercrossed to produce SmoM2/SmoM2
homozygotes. The resulting homozygous mice were subsequently
crossed to MMTV-Cre/+;mT-mG/mT-mG mice. The resulting
SmoM2/mT-mG; Cre+mice allowed for recombined cells expressing
the SmoM2 transgene to be tagged with EGFP while surrounding
cells that did not undergo recombination to remain labeled with
TomatoRed. Immunocompromised SCID/beige mice purchased from
Charles River (Houston, TX) were used as transplantation hosts.
Genotyping of mice was carried out by allele-speciﬁc PCR using
primers listed in Supplemental Table S1. All animals were main-
tained in accordance with the NIH Guide for the Care and Use of
Experimental Animals with approval from the Baylor College of
Medicine Institutional Animal Care and Use Committee.Tissue harvesting and processing
In intact mice, mammary glands were harvested at 5, 7, 9 and
10 weeks of age. Two hours prior to tissue harvest, animals were
injected with 10 μl/gram of body weight of bromodeoxyuridine
(BrdU) (3 mg/ml) in PBS to allow evaluation of proliferation. Vaginal
smears were used, along with the appearance of the vagina and
uterus, to determine the stage of estrus cycle upon harvest.
For whole gland imaging, the #1, 3, 4, and 5mammary glands from
the left side of the animal were collected and processed for whole
mount preparations. For gene expression analysis, the #1, 3, 4
(without the lymph node), and 5 mammary glands from the right
side of the animal were frozen in liquid nitrogen for subsequent
protein, RNA, and DNA extraction.Primary mammary epithelial cell isolation and FACS analysis
For yellow ﬂuorescent protein (YFP) detection by ﬂuorescence
activated cell sorting (FACS) analysis, freshly isolated mammary
epithelial cells (MECs) from individual mice (at least 3 Cre+ and 3
Cre− animals either 9 or 10 weeks of age) were derived from #1, #3,
#4 (without the lymph node) and #5 mammary glands. The glands
were then minced into 1 mm3 fragments using a Vibratome Series
800-Mcllwain Tissue Chopper (Vibratome, St. Louis, MO) and
digested in 2 mg/ml collagenase A (Roche Applied Science, Indiana-
polis, IN) in F12 Nutrient Mixture containing 1× antibiotic–
antimycotic (InVitrogen, Carlsbad, CA) for 1 h at 37 °C with shaking
at 200 rpm. Single cells were puriﬁed as described previously (Welm
et al., 2008). Single cells were resuspended in HBSS containing 2%
FBS and 10 mM HEPES buffer, ﬁltered through a 40 μm cell strainer,
and stained with SytoxRed (InVitrogen) to exclude dead cells.
Samples were analyzed for YFP ﬂuorescence using an LSRII Analyzer
(BD Biosciences, San Jose, CA).Adenovirus transduction and transplantation
For conditional overexpression experiments, freshly isolatedMECs
were incubated with an adenovirus expressing Cre recombinase (Ad-
Cre) to induce recombination (Rijnkels and Rosen, 2001) at a
multiplicity of infection of 50 in 2 ml of 5% FBS/DMEM F12 for 1 h at
37 °C in suspension. The cells were then centrifuged at 450×g for
5 min, washed with 5 ml of 5% FBS/DMEM-F12, and resuspended to
25,000 cells/μl in a 1:1 solution of PBS and Matrigel (BD Biosciences),
on ice until transplantation (Moraes et al., 2007). Cells (250,000/fat
pad) were injected into contralateral cleared fat pads of SCID/Beige
host mice as described previously (Deome et al., 1959). After 8 weeks,
mammary glands were harvested and processed for whole-gland and
histological analysis.
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For untaggedmammary glands, SmoM2;+and SmoM2;MMTV-Cre
animals, the #4 mammary glands were harvested, ﬁxed in ice cold 4%
paraformaldehyde for 2 h, and stained with hematoxylin as described
previously (Daniel et al., 1989). At least ten Cre+and Cre− animals
were analyzed, and three mice of each genotype were used for
quantiﬁcation of branching. Brieﬂy, ten 4× ﬁelds were imaged per
gland on a Leica MZ16F ﬂuorescent stereoscope (Meyer Instruments,
Houston, TX) and all branches counted.
For experiments in which the epithelium was genetically tagged
with the R26R LacZ reporter, after transplantation, contralateral #4
mammary glands (and a host #3 gland as an endogenous control)
were ﬁxed as described above for 1 h and washed three times for
30 min in wash buffer containing 0.2% NP-40, 0.01% sodium
deoxycholate, and 2 mM magnesium chloride in 1× PBS. Glands
were then pre-incubated in wash buffer containing 25 mM potassium
ferrocyanide and 25 mM potassium ferricyanide for 1 h at 37 °C and
stained overnight in the above solution containing 1 mg/ml X-gal
(InVitrogen). Glands were then dehydrated in a series of 70%, 95% and
100% ethanol and imaged. All glands were then embedded in parafﬁn
for further histological analysis.
For ﬂuorescence imaging of whole mount preparations (Landua et
al., 2009) mammary glands 1–5 on the left side of the animal, as well
as salivary gland, uterus and ovaries were harvested, placed onto a 6-
well dish and left in 50% glycerol/PBS rocking overnight at 4 °C. The
next day, tissues were ﬂattened between two glass slides and imaged
using a Leica MZ16F microscope (Meyer Instruments). Tissues were
then ﬁxed as described above and parafﬁn embedded.
Intraductal adenovirus delivery
Adenovirus-Cre and adenovirus-LacZ were diluted to 110 pfu/ml in
Ringer's solution containing bromophenol blue as a marker dye.
Inguinal and thoracic mammary glands of three 6.5 wk old SmoM2/
mTmE mice were injected with 10 μl of Ad-Cre virus (right side) or
Ad-LacZ virus (left side) as previously described (Russell et al., 2003).
Mammary glands were harvested two weeks after injection.
FACS sorting and RNA Isolation and Ampliﬁcation
MECs from Cre+ and Cre+ SmoM2/mTmE 10 wk old mice were
isolated as described above and stained with a lineage panel cocktail
to exclude non-epithelial cells as previously described (LaMarca et al.,
2010). SmoM2;+, SmoM2;Cre (Tomato red), and SmoM2;Cre (EGFP)
cells were then sorted into wildtype Red, Cre Red, and Cre Green
populations by FACS using an AriaII instrument (BD Biosciences).
Total RNA was subsequently isolated using a Qiagen miRNeasy kit,
according to the manufacturer's instructions (Qiagen). RNA was then
analyzed for quality control and cDNA was generated and ampliﬁed
using a NuGEN WT-Ovation RNA Ampliﬁcation kit according to the
manufacturer's instructions (NuGEN).
Immunostaining
Five to seven μm sections were deparafﬁnized and re-hydrated to
PBS through a graded series of ethanols. Heat-induced antigen
retrieval was performed in 10 mM sodium citrate by boiling for
20 min. All washes were performed with PBS and primary antibodies
were incubated at 4 °C overnight. BrdU (1:10, BD Biosciences) and
NKCC1 (1:200, kind gift from Dr. Kim Turner, NIH, Bethesda, MD)
were diluted in 5% BSA, 0.5% Tween blocking buffer, and keratin 8 (K8;
1:200, Developmental Studies Hybridoma Bank, University of Iowa),
K14 (1:200 Covance, Princeton, NJ), EGFP (1:1000, InVitrogen), and
F4/80 (1:200, InVitrogen) were diluted in M.O.M block (Vector
Laboratories, Burlingame, CA). For immunohistochemistry (BrdU,F4/80), Vectastain Elite ABC and diaminobenzidine (DAB) substrate
kits (Vector Laboratories) were used according to the manufacturer's
instructions. Following detection, sections were counterstained with
hematoxylin, and slides coverslipped using Permount (Fisher).
Images were captured using an Olympus BX-40 microscope (Leeds
Instruments, Irving, TX). BrdU-positive cells were counted using
ImagePro Plus 6.1 software (Media Cybernetics, Bethesda, MD) (ﬁve
40× ﬁelds per section, two sections per gland, at least 4 glands for
each genotype). For immunoﬂuorescence, slides were washed with
PBS and incubated with AlexaFluor (InVitrogen) secondary antibodies
(1:200) for 1 h at room temperature, washed in PBS and then
mounted in Vectashield with DAPI (Vector Laboratories).
Quantitative RT-PCR (qPCR)
Total RNA from # 4 mammary glands (after lymph node removal)
was isolated using Trizol Reagent (InVitrogen) according to the
manufacturer's instructions. RNA samples were then DNase-treated
(InVitrogen) and cDNA was synthesized using Superscript III RT kit
(InVitrogen) according to the manufacturer's protocol. For FACS
sorted cells RNA was isolated and ampliﬁed as described above. qPCR
was performed using ABI reagents and Taqman Probe and Primer Sets
(assay ID numbers found in Supplemental Table S2) or SYBRgreen
(Applied Biosystems, Foster City, CA) and were normalized to 18S
ribosomal RNA or ß-actin, respectively. All qPCR was performed using
the StepOnePlus Real-Time PCR System (Applied Biosystems).
Relative levels of expression were calculated using the ΔΔCt method
using Cre-negative litter-mates orWildtype SmoM2;+ populations as
calibrators (Livak and Schmittgen, 2001).
Statistical analysis
Data from branching quantitation and BrdU incorporation are
presented as themeans±standard error of themeans (SEM). SmoM2;
Cre glands were compared to SmoM2;+ glands and the differences
were analyzed using an unpaired Student's t-test (GraphPad Prism©
Home, San Diego, CA.) For gene expression studies differences in
relative quantitation were analyzed using a paired Student's t-test.
Results
Previous analysis of mammary glands from an MMTV-SmoM2
transgenic mouse showed increased proliferation, and ductal hyper-
plasia in virgin mice. In this model, SmoM2 expression was driven by
the MMTV-LTR in a small percentage of mammary epithelial cells. To
ensure that similar changes also occurred in the Cre-dependent
conditional model in which SmoM2was knocked into the ROSA locus,
we harvested mammary glands from SmoM2;+ (wild type) and
SmoM2;Cre (SmoM2 expressing) animals at 5, 7, 9 and 10 weeks of
age and analyzed for overall morphology. Consistent with previous
results using MMTV-SmoM2 mice, at 5 weeks of age there was a
signiﬁcant increase in the number of terminal end buds (TEBs), the
highly proliferative structures that drive ductal morphogenesis in
SmoM2;Cre mice relative to Cre-negative controls (Fig. 1A,B).
Accelerated ductal outgrowth was apparent at 7 weeks of age when
the ductal epithelia from SmoM2;Cre animals reached the end of the
fat pad, in contrast to the ducts from Cre-negative littermates
(SmoM2;+) (Fig. 1A). At 9 weeks of age, ductal epithelia from both
Cre-positive (SmoM2;Cre) and Cre-negative (SmoM2;+) animals
completely ﬁlled the fat pad, and were morphologically indistin-
guishable from one another (Fig. 1A). By ﬂow cytometric analysis,
approximately 45% (44.7±12.78%) of MECs from Cre-positive
animals expressed the SmoM2-YFP fusion protein (Fig. 1 C).
Whereas glands in SmoM2;Cre and SmoM2;+ mice were
indistinguishable at 9 weeks of age, a dramatic phenotypic transi-
tion occurred at 10 weeks of age. Glands from SmoM2;Cre animals
Fig. 1. SmoM2 expression leads to increased number of TEBs and hyper-branching of the mammary gland. Hematoxylin stained whole-mounts of mammary glands from SmoM2;+
or SmoM2;Cre animals at 5, 7, 9 and 10 weeks of age. Cre positive animals exhibit a signiﬁcant increase in number of TEBs at 5 weeks (pb0.01) (B) as well number of branches at
10 weeks (p=0.03) (D) as compared to their Cre negative litter-mates. At 7 weeks of age mammary glands from Cre positive animals have reached the end of the fat pad whereas
their Cre-negative litter-mates have not. At 9 weeks of age, SmoM2;+ and SmoM2;Cre mammary glands are morphologically indistinguishable. FACS analysis for SmoM2-YFP fusion
at 9 weeks showing that approximately 45% of MECs express YFP (C). Scale bars A,B: 5 mm D,E,G,H: 5 mm.
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along the mammary ductal tree compared to Cre-negative litter-
mates (Fig. 1A and D). Additionally, alveolar bud-like structures
were observed throughout the Cre-positive mammary glands that
were reminiscent of alveolar development normally observed
during pregnancy. To ensure that this phenotypic change was not
simply due to a change in the percentage of cells expressing
SmoM2-YFP, we repeated the FACS analysis. Again, approximately
50% (52.2±2.3%) of the MECs from SmoM2;Cre mice expressed the
SmoM2-YFP protein (Fig. S2).
To determine if the morphological and developmental changes
observed were associated with increased proliferation, immunostain-
ing for BrdU incorporationwas used as an indicator for cells in S phase.
At 5 weeks of age, we observed a signiﬁcant increase in BrdU
incorporation in the TEBs of Cre-positive mammary glands relative
to Cre-negative glands (Fig. 2A vs. 2B,C). At 9 weeks of age, the Cre-
negative animals exhibit low levels of proliferation in the mammary
gland, characteristic of the mature virgin state (Fig. 2D), whereas Cre-
positive animals showed a signiﬁcant increase in the number of
proliferating cells (Fig. 2E,F). Unexpectedly, at 10 weeks of age, there
was no difference in proliferation between SmoM2;Cre and SmoM2;+
mice (Fig. 2G–I), with ductal epithelium showing approximately 2%
BrdU positive cells.Epithelial SmoM2 expression disrupts histoarchitecture, increases
periductal collagen deposition, and increases macrophage recruitment
Histological examination of mammary gland sections from
10-week-old mice revealed the presence of alveolar-like structures
in the Cre-positive mammary glands as compared to controls
(Fig. 3A,B). Cre-positive mammary glands also exhibited dissocia-
tion of the luminal and myoepithelial cell layers, and luminal cells
had an enlarged, clear cytoplasm as compared to Cre-negative
littermates. Additionally, the periductal stroma surrounding the
hyper-branched Cre-positive 10-week old mammary glands was
thickened with an increase in stromal cellularity. In order to
characterize the thickened stroma, Masson's Trichrome staining was
performed, which revealed an increase in collagen deposition
surrounding the ducts of the Cre-positive glands (blue staining)
(Fig. 3C,D). To help determine the identity of the cells in the
periductal stroma, we performed immunohistochemical staining for
F4/80, a macrophage marker. This revealed a marked increase in
macrophages in the periductal stroma in approximately 50% of the
SmoM2;Cre glands (Fig. 3F) as compared to SmoM2;+ controls
(Fig. 3E). Taken together, these data indicate that SmoM2
expression in the mammary epithelium results in alterations in
the mammary gland stromal microenvironment.
Fig. 2. SmoM2 expression leads to increased proliferation in the developing mammary gland. Immunohistochemistry for BrdU in parafﬁn embedded mammary gland sections from
SmoM2;+ (A,D,G) and SmoM2;Cre (B,E,H) animals at 5, 9 and 10 weeks of age. SmoM2;Cre animals exhibit an increase in proliferation in the TEB's at 5 weeks of age (p=0.03) (C)
that persists until 9 weeks of age (pb0.01) (F). By 10 weeks of age, the level of proliferation between SmoM2;Cre and SmoM2;+ littermates is not signiﬁcantly different (I). Scale
bars: 100 μm.
Fig. 3. SmoM2 expression leads to histological changes in the mammary gland
epithelium and stroma. H&E (A,B) and Masson's Trichrome (C,D) staining of SmoM2;+
and SmoM2;Cre mammary gland sections. F4/80 immunostaining for macrophages in
SmoM2;+ (E) and SmoM2;Cre (F) mammary gland sections. Arrows denote positive
staining. Scale bars A–F: 100 μm.
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myoepithelium for the observed mammary gland defects
In order to study the effect of SmoM2 expression in different cell
types in the mammary gland, we employed adenoviral-Cre (Ad-Cre)
infection in vitro on freshly isolated MECs from SmoM2;+ mice
followed by subsequent transplantation. First SmoM2 mice were
crossed to the R26R line, a lacZ reporter for Cre expression. MECs
from SmoM2; R26R animals and R26R animals as a control were
obtained and transduced with Ad-Cre to induce recombination. Ad-
Cre elicits recombination in multiple cell types including stem and
lineage-restricted progenitor cells. As a result, chimeric outgrowths
containing recombined and un-recombined areas, as well as
outgrowths in which only luminal or myoepithelial cell-types
underwent recombination were obtained. Every outgrowth from
the Ad-Cre treated SmoM2 MECs (8/8) was either hyper-branched
and budded, or displayed aberrant TEB structures, or in some cases
both phenotypes. A representative example of the outgrowths
obtained is shown in Fig. 4. Control R26R outgrowths appeared
normal and exhibited radial outgrowth as well as a moderate level
of side branching (Fig. 4A,B). In contrast, SmoM2;R26R outgrowths
exhibited hyper-branching and budding and also appeared disor-
ganized (Fig. 4C,D). A chimeric SmoM2;R26R outgrowth is depicted
in Fig. 4E. Recombined areas of the outgrowth (illustrated by the
blue X-gal staining) showed hyper-branching and budding as
compared to the un-recombined (dashed box) conﬁrming that
only areas containing SmoM2 expressing cells exhibit the hyper-
branched phenotype observed. Signiﬁcantly, areas of the out-
growths consisting of only a recombined myoepithelial cell layer
with un-recombined luminal epithelium (observed in multiple
ducts from three independent outgrowths) did not display the
Fig. 4.Mammary gland reconstitution experiments after Ad-Cre treatment reveal a requirement for SmoM2 in luminal epithelium. X-gal stained whole-mounts and H&E sections of
mammary gland outgrowths from R26R (A,B) and SmoM2;R26R (C–G) MECs illustrating how SmoM2 expressing cells participate in the hyper-branching phenotypes observed.
Panel G illustrates an outgrowth in which only the myoepithelial cell layer underwent recombination. Scale bars: A,C,E 5 mm; B,D 100 μm; F,G 50 μm; Insets 20 μm.
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expression in the luminal epithelium is required for the formation
of the hyper-branched and budded mammary ductal trees and the
changes in luminal, myoepithelial and periductal histology as
illustrated in Fig. 4F.
The ductal hyperplasia phenotype requires interactions between
SmoM2-expressing and wild type cells
In order to examine the consequences of activated Smo in SmoM2-
expressing cells, non-expressing cells, and the surrounding environ-
ment more effectively, we crossed the SmoM2 animals to mice
carrying a dual ﬂuorescent reporter for Cre activity targeted to the
Rosa26 locus (mT-mG). Cells in which SmoM2 is activated by Cre-
mediated recombination express Cre-dependent EGFP, while cells in
which SmoM2 is not activated by recombination remain Tomato Red-
positive. Fluorescent imaging of whole mammary glands indicated
that neither Cre-negative control mice (Fig. 5A) nor Cre-positive mice
lacking the conditional SmoM2 allele (Fig. 5B) showed evidence of
hyperplasia. In contrast, SmoM2;Cre mice exhibiting recombination
(EGFP expression) showed hyper-branching and budding of the
mammary ductal tree (Fig. 5C). However, areas of the mammary
glands that exhibited 100% recombination did not display the
hyperplastic phenotype (Fig. 5D–F). The hyper-branched and budded
phenotype was only present in chimeric outgrowths containing both
recombined (SmoM2-expressing) and un-recombined cells (Fig. 5G–
I). These results demonstrate that wild type cells are required in orderfor the hyper-branching to occur, and further suggest that this
phenotype is dependent upon either a paracrine or juxtacrine cell–cell
interaction between the SmoM2 expressing cells and nearbywild type
cells.
SmoM2-expressing cells stimulate the proliferation of neighboring wild
type cells in a paracrine or juxtacrine manner
To demonstrate whether SmoM2 expressing cells stimulate
proliferation of wild type cells in a paracrine or juxtacrine manner,
we employed intraductal Ad-Cre delivery to activate SmoM2 and
EGFP expression, with contralateral injection of adenoviral-LacZ as a
negative control. This technique allowed us to achieve SmoM2
expression in situ in only a subset of cells, and to examine the effects
on surrounding cells at speciﬁc times after SmoM2 expression. Two
weeks after injections, the glands were harvested following a two-
hour BrdU pulse and processed for staining. Co-staining for EGFP
and BrdU revealed a signiﬁcant increase in proliferation in cells
surrounding SmoM2 expressing (EGFP positive) cells (Fig. 6A).
Quantiﬁcation of the staining (Fig. 6B) demonstrated that 14%
(±4.1%) of the cells exhibited recombination (as determined by
EGFP expression) in Ad-Cre treated ducts and Ad-lacZ treated ducts
exhibited no recombination. Ad-Cre treated ducts showed a
signiﬁcant increase in BrdU incorporation (2.91±0.8%) as compared
to Ad-lacZ treated ducts (0.21±0.1%) (p=0.01). Signiﬁcantly, in
Ad-Cre treated ducts, the majority of proliferation occurred in un-
recombined cells (2.67±0.73%), but not in EGFP expressing cells
Fig. 5. Tagged SmoM2;Cre mammary glands exhibit hyper-branching and budding and reveal a possible requirement for SmoM2–wildtype cell interactions. Fluorescent images of
whole glands from SmoM2;Cre and SmoM2;+, and +;Cre mammary glands illustrating un-recombined (Tomato Red+) and recombined (EGFP+) areas of the glands. Recombined
cells marked by reporter EGFP expression have SmoM2 transgene expression. Merged image of a SmoM2;+ mammary gland (A). Merged image of a wild type; Cre positive
mammary gland illustrating that EGFP expression alone is not responsible for the observed phenotypes (B). Merged image of a SmoM2;Cre mammary gland (C). Red, green, and
merged images of sections from the same SmoM2;Cre mammary gland illustrating the requirement for un-recombined (Tomato Red+) cells in order for the presence of the hyper-
branching phenotype (D–I). Scale bars A–C: 5 mm D–I: 5 mm.
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stimulating the proliferation of the surrounding wildtype cells while
not signiﬁcantly increasing proliferation in the SmoM2 expressing
cells themselves. It is important to note that within Ad-Cre treated
ducts, the increase in proliferative un-recombined (Tomato Red+)
cells was only observed in those ducts containing at least one
recombined (EGFP+) cell (Fig. S3), indicating that the proliferative
stimulus from the SmoM2 cells requires either a close proximity or
direct contact with wildtype cells.Fig. 6. SmoM2 expression stimulates proliferation of neighboring wildtype cells. Co-immunos
right side (4R) was injected with Ad-Cre and the left side (4L) was injected with Ad-LacZ
recombination and SmoM2 expression. Ad-Cre injected glands had a signiﬁcant (p=0.01) in
glands. The majority of proliferating cells (BrdU positive) were un-recombined cells (2.67±SmoM2-expressing cells exhibit increased Hh signaling activity and
possible downregulation of Notch pathway activity
In previously published models of Hh signaling activation in the
mammary gland, the hallmark transcriptional targets of high level Hh
signaling were not detected (Moraes et al., 2009, 2007). Several
studies have suggested that canonical Hh signaling must be kept in a
repressed state for normal virgin mammary gland development to
occur (Hatsell and Cowin, 2006). In order to determine if SmoM2taining for EGFP and BrdU in contralaterally injected inguinal mammary glands (A). The
as control. Ad-Cre injected glands exhibited 14%±4.1% EGFP expression, a marker for
crease in the number of cells expressing BrdU as compared to Ad-LacZ injected control
0.73%) as compared to 0.24±0.05% of BrdU positive EGFP expressing cells (B).
123A.P. Visbal et al. / Developmental Biology 352 (2011) 116–127expression could elicit a canonical Hh transcriptional response, we
took advantage of our taggedmousemodel to sort recombined (EGFP)
and un-recombined (Tomato Red) MEC populations from SmoM2;Cre
mice and wildtype MECs from SmoM2;+ littermates (Fig. 7A). Total
RNA was isolated from epithelial-enriched cell populations and qPCR
was performed. As expected, SmoM2 transgene expression was
increased 13-fold (±4.8) in EGFP-positive SmoM2:Cre MECs com-
pared to the un-recombined Tomato Red-positive population
(Fig. 7B). Fig. 7C illustrates the gene expression of the Hh signal
pathway components in all three sorted cell populations. An induction
of Gli2 (18±7.2 fold change p=0.03) expression as well as a marked
increase of Gli1 (71±24.2 fold change p=0.04) and Ptch2 (55±20.3
fold change p=0.04) was observed in EGFP+ (recombined) SmoM2;
Cre MECs as compared to SmoM2;+ cells. An induction (5±0.9 fold)
in Gli2 was observed in Tomato Red+ (un-recombined) cells.
Additionally, and induction of Smo expression was observed in both
recombined (EGFP+) and un-recombined (Tomato Red+) cells from
SmoM2;Cre mice as compared to cells from Cre negative litter-mates.
These data indicate that activation of canonical Hh signaling occurred
in the SmoM2 expressing cells.
Since SmoM2-expressing cells were stimulating proliferation of
wildtype cells adjacent or in-close proximity, we next investigated
whether expression of members of the Notch signaling pathway,
which is known to function in a juxtacrine manner, was altered.
Fig. 7D illustrates the gene expression patterns of several Notch
pathway members in all three sorted cell populations. A marked
upregulation of the Notch ligands delta-like 1 (Dll-1), (21±6.8 fold
change p=0.02) and Jagged-2 (Jag2) (5±1.0 fold change pb0.01)
was detected in EGFP+ (recombined) cells from SmoM2;Cre mice, as
compared to wildtype MECs from SmoM2;+ mice. Additionally, theFig. 7. SmoM2 expressing cells have active Hh signaling and downregulation of the Notch pa
MECs and Tomato Red expressing (un-recombined) SmoM2;Cre MEC populations (A). Quant
expressing (recombined) SmoM2;Cre MECs as compared to Tomato Red expressing (un-reco
illustrating induction of Ptch2 (p=0.04), Gli-1 (p=0.04), and Gli-2 (p=0.03) in EGFP exp
Notch pathway gene expression in sorted cell populations illustrating the 23-fold increased e
18-fold downregulation of Notch4 (pb0.0001), the 14-fold downregulation of Dll-4 (p=0.0
SmoM2;Cre MECs as compared to wildtype SmoM2;+ MECs.Notch 4 receptor (18±11.9 fold change pb0.01) along with the Hes6
target gene (7±3.7 fold change p=0.03) and the Delta-like 4 (Dll4)
ligand (14±9.1 fold change pb0.01) were found to be downregulated
in the EGFP-positive cell population. The Notch1 receptor was found
to be slightly upregulated (less than 1 fold) in both EGFP and
TomatoRed populations. No signiﬁcant changes were observed in
other pathway members tested.
Epithelial SmoM2 expression disrupts luminal–myoepithelial cell
interactions and alters luminal epithelial cell differentiation
In order to determine if the morphological changes observed
after SmoM2 expression were due to aberrant differentiation and
organization of distinct mammary epithelial cell subtypes, we
examined the luminal and myoepithelial cell layers by immunos-
taining with antibodies that detect keratin 8 (K8), a luminal cell
marker and keratin 14 (K14), a myoepithelial cell marker (Fig. 8).
While both of these markers were readily detected in SmoM2;Cre
glands, the typical bilayer of ductal epithelium was disrupted as
compared to SmoM2;+ controls. Furthermore, K14-expressing cells
were rounded as opposed to their characteristic elongated shape
(Fig. 8B), and appeared dissociated from the luminal cells and
possibly from the basement membrane (Fig. 8A vs. 8B and insets). In
this trigenic model, recombination and SmoM2 expression (as
measured by EGFP detection) occurs in both luminal and myoe-
pithelial cell layers (Fig. S4).
In order to determine if the dissociation of the mammary gland
bilayer was due to expression of SmoM2 in the myoepithelial cell
layer, we examined K8-K14 expression in SmoM2/mT-mE glands
injected intraductally with Ad-Cre. Serial sections were stained forthway. Representative FACS plot illustrating EGFP expressing (recombined) SmoM2;Cre
itative RT-PCR illustrating the 13-fold increased expression of SmoM2 (p=.03) in EGFP
mbined) SmoM2;Cre MECs (B). Hh pathway gene expression in sorted cell populations
ressing (recombined) SmoM2;Cre MECs as compared to wildtype SmoM2;+ MECs (C).
xpression of Dll-1 (p=0.02), the 5-fold increased expression of Jag2 (pb0.01), and the
3) and the 7-fold downregulation of Hes6 (p=0.03) in EGFP expressing (recombined)
Fig. 8. SmoM2 expression leads dissociation between the luminal andmyoepithelial cell
layers. Co-immunostaining for luminal marker kertain-8 (K8) and myoepithelial cell
marker keratin-14 (K14) in SmoM2;+ (A) and SmoM2;Cre (B) mammary glands.
Mammary glands from SmoM;Cre mice exhibit dissociation of the luminal and
myoepithelial cell layer (B) and altered morphology of the myoepithelial cells (B inset)
as compared to Cre negative litter-mates (A). Co-immunostaining for EGFP (as amarker
for SmoM2 expression) and K14 (C,E) and K8-K14 (D,F) in serial sections from
mammary glands from SmoM2/mTmG mice intraductally injected with Ad-Cre. The
dissociation of the luminal and myoepithelial cell layers was not observed in ducts
lacking EGFP expression (C,D) and only present in ducts with luminal EGFP expression
(E,F). Insets are magniﬁcations depicting the luminal and myoepithelial cell interface.
Arrows indicate K14 positive cells that have lost their characteristic elongated shape.
Scale bars A–F: 75 μm Insets: 10 μm.
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(Fig. 8D,F) in order to examine the bilayer interaction in areas with
low or no recombination as well as in areas with high levels of SmoM2
expression. Disruption of the luminal and myoepithelial cell layers
was only apparent in ducts containing EGFP expression in luminal
cells (Fig. 8E,F) as compared to ducts containing no EGFP expression
(Fig. 8C,D). Ad-lacZ injected glands exhibited the normal pattern of K8
and K14 expression and typical bilayer interaction and appeared
indistinguishable from the Ad-Cre injected ducts with no EGFP
expression (Fig. S5). Since recombination in the Ad-Cre injected
glands occurs primarily in the luminal epithelium (Fig. S6), it is likely
that SmoM2 transgene expression in only the luminal compartment is
sufﬁcient for the observed phenotypes.
To examine the proper differentiation of luminal epithelial cells
further, particularly with respect to hyperplastic alveolar buds, we
performed immunostaining for a speciﬁc marker for the transition
from luminal to alveolar cells. The Na–K–Cl co-transporter-1 (NKCC1)
is normally expressed throughout the differentiated luminal epithe-
lium of virgin mammary glands and is absent in alveolar cells during
pregnancy (Shillingford et al., 2002). SmoM2;Cre mammary glands
showed loss of NKCC1 expression in a large percentage of cells as
compared to SmoM2;+ littermates (Fig. 9A,B). This loss of expression
occurred not only in the alveolar-like cells as seen during pregnancy,but also throughout the ductal epithelium in virgin mice. We also
examined NKCC1 expression in Ad-Cre and Ad-LacZ injected glands
and found that in comparison to Ad-LacZ treated glands (Fig. 9C) this
marker again was absent in Ad-Cre injected glands predominantly in
SmoM2 (EGFP+) cells (Fig. 9D). Arrows illustrate regions of the duct
in which NKCC1 expression is absent.
Despite these changes in differentiation, no detectable changes in
the expression or distribution of estrogen receptor (ER) or proges-
terone receptor (PR) were observed (data not shown). Therefore,
these studies suggest that although SmoM2;Cre glands still maintain a
distinct luminal and myoepithelial cell identity as well as normal
levels of hormone receptors, SmoM2 expression in the luminal
epithelium is sufﬁcient to cause altered luminal cell differentiation
and disrupted interactions between the luminal and myoepithelial
cell layers.
Discussion
In this study, we report that SmoM2 expression in luminal
mammary epithelium, but not myoepithelium, leads to increased
proliferation as well as to defects in mammary gland morphology.
Developmental defects are associated with changes in luminal–
myoepithelial cell–cell interactions as well as to altered epithelial–
stromal tissue interactions. Using genetically tagged mammary gland
chimeras, as well as adenoviral induced chimeras, we show that
SmoM2 expressing cells are capable of stimulating proliferation in
neighboring wild type cells, demonstrating that either a paracrine or
juxtacrine mechanism may be responsible for the observed effects.
Finally, we show that SmoM2 expression leads to an upregulation of
the canonical Hh transcription factors Gli1 and Gli2 as well as to
upregulation of the canonical target Ptch2. Additionally, SmoM2
expression leads to upregulation of notch pathway ligands Dll-1, and
Jag2, as well as to downregulation of the notch pathway receptor
Notch4 and of target gene Hes6, suggesting a cooperation of these two
pathways in eliciting the observed phenotypes.
Stimulation of proliferation by SmoM2 expressing cells
Previous analysis of SmoM2 expression in the mammary gland
showed alterations in mammary gland morphology and increased
proliferation (Moraes et al., 2007). However, while results suggested
that paracrine cell–cell interactions might be responsible for the
observed proliferative phenotype, this hypothesis could not be
formally tested using available models. In this study, we were able
to generate adenoviral induced tagged chimeras that allowed us to
demonstrate conclusively that SmoM2 expression stimulated prolif-
eration of surrounding wildtype cells. The adenoviral-induced
chimeras have the advantage that they produce ducts with both
recombined and un-recombined cells in the same mammary gland.
Furthermore, an adenovirus lacking the Cre recombinase can be
injected in the same mouse facilitating a comparison with the
contralateral mammary gland, thus providing ideal controls for any
systemic effects. Our observations that hyper-proliferation in re-
sponse to SmoM2 cells only occurred in ducts containing recombined
cells and that 50% of proliferating cells observed were in direct cell
contact with a SmoM2 expressing cell, provide strong evidence for
either a short range paracrine- or juxtacrine-mediated effect.
Although many reports of induced proliferation resulting from the
canonical activation of the Hh pathway exist, we now demonstrate
that this effect can be non-cell autonomous— a possibility that cannot
generally be easily tested in most other developmental models.
Increased expression of Ptch2, Gli1, and Gli2
In previously published models of Hh signaling activation in the
mammary gland, the hallmark transcriptional targets of high level Hh
Fig. 9. SmoM2 expression leads to changes in luminal epithelial cell identity. Single channel and merged images of co-immunostaining for EGFP and NKCC1 in SmoM2;+ (A),
SmoM2;Cre (B) and in SmoM2/mTmE glands intraductally injected with Ad-LacZ (C) and Ad-Cre (D). NKCC1 expression was not detected in a large population of cells in mammary
glands from SmoM2;Cre mice relative to litter-mate controls. In glands injected intraductally with Ad-Cre, NKCC1was not detected predominantly in EGFP expressing cells (arrows).
Scale bars A–F: 50 μm.
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tagged model we were able to analyze gene expression in SmoM2
expressing and surrounding wildtype cells selectively. We demon-
strated a robust activation of the canonical Hh pathway as revealed by
Gli1 and Gli2 upregulation as well as upregulation of the Ptch2
receptor in SmoM2 expressing cells. The discrepancy between the
models appears to be due to masking of the transcriptional response
when using total mammary gland RNA representing both epithelial
and stromal cells. In support of this interpretation, following RNA
isolation from the total mammary gland we only detected a two-fold
increase in Gli1 expression with the conditional SmoM2 model (Fig.
S7), whereas in the FACS puriﬁed SmoM2 expressing cells we
detected a 71-fold increase in Gli1 and an 18-fold increase in Gli2.
With respect to Gli1, Gli1 overexpression in the virgin mammary
epithelium did not result in a detectable phenotype. Lack of a
demonstrable phenotype was attributed to low transgene expression
at this stage of development (Fiaschi et al., 2007). However, during
pregnancy and lactation the transgene was detectable leading to
failure of differentiation during pregnancy and defective lactation.
Pregnancy associated proliferation was increased and recruitment of
periductalmacrophages was also reported, similar to our observations
in virgin mice.
Upregulation of Notch pathway ligands Dll-1 and Jag-2 and
downregulation of Notch pathway receptor Notch4 and target gene Hes6
The observed increase in Dll-1 and Jag2 in MECs that over
expressed SmoM2 has several possible implications. Notch signaling
in the mammary gland has been shown to promote luminal cell fate
determination and repress mammary stem cell expansion in vivo(Bouras et al., 2008; Yalcin-Ozuysal et al., 2010), both of which are
observed in SmoM2 overexpressing mouse models ((Moraes et al.,
2007) and this work). Additionally, activated Notch signaling has also
been shown to elicit a graded response in humanmammary epithelial
cells. Low Notch activity stimulated a hyper-proliferative response,
while high Notch activity caused downregulation of matrix-adhesion
genes and inhibition of proliferation (Mazzone et al., 2010). Since
increased ligand expression can stimulate Notch pathway activity
transiently in the surrounding cells, and also down regulate Notch
activity in the signaling cell via cis-inactivation (consistent with our
observation of Notch4 and Hes6 downregulation in the SmoM2
expressing cell population), this model of Notch pathway activity
might explain the hyper-proliferative response observed in wildtype
cells surrounding SmoM2 expressing cells. Furthermore Dll1, which
has been historically considered solely as a Notch receptor ligand, was
recently shown to have signaling properties when cleaved and bind to
the Smad family of proteins to modulate transcription of genes
downstream of the TGF-β/Activin pathway (Hiratochi et al., 2007).
TGF-β signaling has been shown to act as a negative signal for
proliferation in the mammary gland and to restrict branching
morphogenesis (Sternlicht, 2006). This mechanism may account for
the failure to observe proliferation of SmoM2-expressing cells, and
furthermore explain why proliferation levels in SmoM;Cre glands
revert to normal at ten weeks of age. The only discrepancy to the
proposedmodel is the observed transcriptional downregulation of the
Dll-4 ligand in the SmoM2 expressing cell population. Although
surprising due to the marked upregulation of the other ligands, this
observation may be explained by data indicating that Notch ligands
can exert opposing roles. It is well documented that Dll-4 and Jag1 can
exert opposing roles during vascular development (Benedito et al.,
126 A.P. Visbal et al. / Developmental Biology 352 (2011) 116–1272009). If this is the case in the mammary gland, it is likely that
upregulation of some ligands can in-turn produce downregulation of
others.
Alterations in cell differentiation and disruption of luminal–
myoepithelial cell interactions
Myoepithelial cells have been shown to modulate epithelial–
stromal interactions and to actively participate in the composition and
organization of the extracellular matrix (ECM) (Faraldo et al., 2005). It
is possible that the stromal phenotypes observed in these studies are a
direct result of SmoM2 expression in myoepithelial cells. However,
evidence from the mammary gland chimeras obtained in the
transplantation studies would argue that this effect must be indirect
from the luminal epithelial cells since SmoM2 expression in the
myoepithelial cell layer alone was insufﬁcient to elicit the observed
stromal defects. This ﬁnding suggests that either myoepithelial cells
are not competent to transduce the SmoM2 signal, or that they are
unable to relay a secondary signal following SmoM2 expression.
Another possibility is that the effects seen in the stroma are due to the
observed dissociation between luminal and myoepithelial cells.
Myoepithelial cells mediate the cross talk between luminal cells and
the stroma and these interactions are thought to be required for
appropriate growth, branching and differentiation of the mammary
gland (Faraldo et al., 2005). If this cross-talk were disrupted as a result
of SmoM2 expression in luminal cells and their dissociation from
myoepithelial cells, then the tight control required to regulate the
appropriate amount of side branching and ECM components might be
altered.
NKCC1 expression has traditionally been associated with a
differentiated luminal cell fate and is lost in cells that transition to
an alveolar cell fate during pregnancy. The fact that loss of NKCC1
occurs throughout the gland in the trigenic animals and not
exclusively in the alveolar like buds as it occurs during pregnancy is
an interesting observation. Additionally, in the adenoviral induced
chimeric model, loss of NKCC1 is only apparent in ducts containing
recombined cells and appears to be primarily lost in SmoM2
expressing cells, suggesting that it is a cell-autonomous effect.
When these results are considered in the context of Notch pathway
activity and its role in promoting luminal cell fate determination, they
support a hypothesis in which a decrease in Notch pathway activity in
SmoM2 expressing cells, as evidenced by loss of Notch4 and Hes6
expression and high expression of Dll-1 and Jag2 ligands, might
account for this apparent change in cell differentiation. Thus, if
SmoM2 expressing cells are no longer able to maintain a fully
differentiated luminal cell fate, this might account for their loss of
NKCC1 expression. This hypothesis might also explain previous
observations of increased mammary gland progenitor cells following
SmoM2 expression (Moraes et al., 2007).
Conclusions and other considerations
In conclusion, SmoM2 expression in the mammary gland appears
to exert both cell-autonomous and non-cell autonomous effects.
While it is able to stimulate the proliferation of wildtype MECs as well
as to alter their morphology and myoepithelial–luminal cell organi-
zation, this process appears to be tightly regulated and may be
inﬂuenced by a negative feedback mechanism (e.g. TGF-β signaling).
Furthermore, SmoM2 expression in the mammary epithelium results
in changes in the mammary gland microenvironment.
Despite the proliferative effects and the changes in histoarchitec-
ture observed in SmoM2 expressing glands, these do not progress to
form tumors at a higher rate than that observed in wild type mice.
While SmoM2 expression alone might not be sufﬁcient to elicit a
tumor phenotype, it might provide the appropriate environment in
which to acquire a second hit in the transformation from normal totumor. This hypothesis is being tested explicitly in our laboratory.
Evidence from other models of Hh activation supports the hypothesis
that activation of Hh signaling alone might not be sufﬁcient to induce
mammary tumorigenesis. SmoM2 expression under the control of the
MMTV promoter failed to show an increase in tumor formation
(Moraes et al., 2007). Additionally, long-term tumor formation studies
in Ptch1 heterozygotes did not show increased frequency of mammary
tumors (Goodrich et al., 1997). Finally, targeted mammary gland
overexpression of Gli1 produced tumors, but only after multiple
pregnancies, suggesting that Gli1 expression alone is not sufﬁcient to
elicit mammary tumors (Fiaschi et al., 2009). These observations are
in agreement with human breast cancer data where Smo is highly
expressed in approximately 70% of ductal carcinomas in situ, early
breast cancer lesions, but only over-expressed in about 30% of
invasive breast cancers.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.01.025.
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